NERM
CAVM

New England Research & Management’s Cavium, Inc. CAVM Stock Holding History

New England Research & Management’s Portfolio CAVM Stock Details CAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5,050
Closed -$362K – 182
2017
Q1 		$362K Buy
5,050
+1,764
+54% +$118K 0.28% 112
2016
Q4 		$200K Buy
+3,286
New +$190K 0.16% 167

Other funds holding CAVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AIM
abrdn Investment Management Edinburgh, United Kingdom $29.6B AUM 25.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

New England Research & Management's CAVM Position: Q2 2017 in Review

New England Research & Management sold out of Cavium, Inc. (CAVM) in Q2 2017, closing a stake of 5,050 shares — an estimated $362K sold.

New England Research & Management first reported a position in CAVM in Q4 2016 and held it in 2 quarters. The position peaked at $362K in Q1 2017. 250 funds tracked by Wall St. Rank hold CAVM as of Q2 2017.

  • New England Research & Management reported no remaining Cavium, Inc. position as of Q2 2017 after selling out during the quarter.
  • New England Research & Management sold 5,050 Cavium, Inc. shares in Q2 2017, an estimated $362K.
  • New England Research & Management first reported a position in Cavium, Inc. in Q4 2016 and held it in 2 quarters.
  • New England Research & Management's Cavium, Inc. position peaked at $362K in Q1 2017.
  • 250 funds tracked by Wall St. Rank held Cavium, Inc. as of Q2 2017.

Based on New England Research & Management's 13F filing for Q2 2017, filed 11 Jul 2017.